
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation
Marijana Vujković, Shweta Ramdas, Kimberly Lorenz, et al.
Nature Genetics (2022) Vol. 54, Iss. 6, pp. 761-771
Open Access | Times Cited: 133
Marijana Vujković, Shweta Ramdas, Kimberly Lorenz, et al.
Nature Genetics (2022) Vol. 54, Iss. 6, pp. 761-771
Open Access | Times Cited: 133
Showing 1-25 of 133 citing articles:
Genome-wide association studies of metabolites in Finnish men identify disease-relevant loci
Xianyong Yin, Lap Sum Chan, Debraj Bose, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 115
Xianyong Yin, Lap Sum Chan, Debraj Bose, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 115
Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis
Delilah Hendriks, Jos F. Brouwers, Karien M. Hamer, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 11, pp. 1567-1581
Open Access | Times Cited: 99
Delilah Hendriks, Jos F. Brouwers, Karien M. Hamer, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 11, pp. 1567-1581
Open Access | Times Cited: 99
Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease
Yanhua Chen, Xiaomeng Du, Annapurna Kuppa, et al.
Nature Genetics (2023) Vol. 55, Iss. 10, pp. 1640-1650
Open Access | Times Cited: 79
Yanhua Chen, Xiaomeng Du, Annapurna Kuppa, et al.
Nature Genetics (2023) Vol. 55, Iss. 10, pp. 1640-1650
Open Access | Times Cited: 79
PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis
Vincent Chen, Antonino Oliveri, Matthew J. Miller, et al.
Gastroenterology (2023) Vol. 164, Iss. 6, pp. 966-977.e17
Closed Access | Times Cited: 55
Vincent Chen, Antonino Oliveri, Matthew J. Miller, et al.
Gastroenterology (2023) Vol. 164, Iss. 6, pp. 966-977.e17
Closed Access | Times Cited: 55
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 50
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 50
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank
Panpan He, Yanjun Zhang, Ziliang Ye, et al.
Metabolism (2023) Vol. 146, pp. 155643-155643
Closed Access | Times Cited: 39
Panpan He, Yanjun Zhang, Ziliang Ye, et al.
Metabolism (2023) Vol. 146, pp. 155643-155643
Closed Access | Times Cited: 39
Diabetes mellitus—Progress and opportunities in the evolving epidemic
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 27
E. Dale Abel, Anna L. Gloyn, Carmella Evans‐Molina, et al.
Cell (2024) Vol. 187, Iss. 15, pp. 3789-3820
Closed Access | Times Cited: 27
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis
Jonas Ghouse, Garðar Sveinbjörnsson, Marijana Vujković, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 827-837
Open Access | Times Cited: 14
Jonas Ghouse, Garðar Sveinbjörnsson, Marijana Vujković, et al.
Nature Genetics (2024) Vol. 56, Iss. 5, pp. 827-837
Open Access | Times Cited: 14
Hepatocyte mARC1 promotes fatty liver disease
Lara C. Lewis, Lingyan Chen, L. Shahul Hameed, et al.
JHEP Reports (2023) Vol. 5, Iss. 5, pp. 100693-100693
Open Access | Times Cited: 26
Lara C. Lewis, Lingyan Chen, L. Shahul Hameed, et al.
JHEP Reports (2023) Vol. 5, Iss. 5, pp. 100693-100693
Open Access | Times Cited: 26
Advances in the genetics of nonalcoholic fatty liver disease
Veeral Ajmera, Rohit Loomba
Current Opinion in Gastroenterology (2023) Vol. 39, Iss. 3, pp. 150-155
Open Access | Times Cited: 22
Veeral Ajmera, Rohit Loomba
Current Opinion in Gastroenterology (2023) Vol. 39, Iss. 3, pp. 150-155
Open Access | Times Cited: 22
Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
Scott L. Friedman
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 2, pp. 161-169
Open Access | Times Cited: 14
Scott L. Friedman
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 2, pp. 161-169
Open Access | Times Cited: 14
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 345-359
Open Access | Times Cited: 12
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 345-359
Open Access | Times Cited: 12
Genetics of MASLD: The State of Art Update.
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 11
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 11
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease
Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, et al.
Nature Medicine (2024)
Open Access | Times Cited: 10
Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, et al.
Nature Medicine (2024)
Open Access | Times Cited: 10
Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer
Altayeb Ahmed, Madeleine Cule, Jimmy D. Bell, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 921-929
Open Access | Times Cited: 9
Altayeb Ahmed, Madeleine Cule, Jimmy D. Bell, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 921-929
Open Access | Times Cited: 9
Insulin resistance is an integral feature of MASLD even in the presence of PNPLA3 variants
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101092-101092
Open Access | Times Cited: 8
Fernando Bril, Srilaxmi Kalavalapalli, Romina Lomonaco, et al.
JHEP Reports (2024) Vol. 6, Iss. 7, pp. 101092-101092
Open Access | Times Cited: 8
Non‐alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study
Ningyuan Liu, Ge Wang, Chao Liu, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 365-376
Closed Access | Times Cited: 31
Ningyuan Liu, Ge Wang, Chao Liu, et al.
Diabetes Obesity and Metabolism (2022) Vol. 25, Iss. 2, pp. 365-376
Closed Access | Times Cited: 31
Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis
Junjie Zhang, Yan Shen, Xiaohong Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
Junjie Zhang, Yan Shen, Xiaohong Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 20
Disruption of CerS6-mediated sphingolipid metabolism by FTO deficiency aggravates ulcerative colitis
Yanru Ma, Xinyu Zhang, Baoqin Xuan, et al.
Gut (2023) Vol. 73, Iss. 2, pp. 268-281
Closed Access | Times Cited: 20
Yanru Ma, Xinyu Zhang, Baoqin Xuan, et al.
Gut (2023) Vol. 73, Iss. 2, pp. 268-281
Closed Access | Times Cited: 20
Noninvasive assessment of organ-specific and shared pathways in multi-organ fibrosis using T1 mapping
Victor Nauffal, Marcus D. R. Klarqvist, Matthew C. Hill, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1749-1760
Closed Access | Times Cited: 7
Victor Nauffal, Marcus D. R. Klarqvist, Matthew C. Hill, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1749-1760
Closed Access | Times Cited: 7
A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids
Leonida Hehl, Kate Townsend Creasy, Cecilia Vitali, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 5
Leonida Hehl, Kate Townsend Creasy, Cecilia Vitali, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 5
MetALD: Does it require a different therapeutic option?
George Marek, Harmeet Malhi
Hepatology (2024) Vol. 80, Iss. 6, pp. 1424-1440
Closed Access | Times Cited: 5
George Marek, Harmeet Malhi
Hepatology (2024) Vol. 80, Iss. 6, pp. 1424-1440
Closed Access | Times Cited: 5
Mapping biological influences on the human plasma proteome beyond the genome
Julia Carrasco-Zanini, Eleanor Wheeler, Burulça Uluvar, et al.
Nature Metabolism (2024)
Open Access | Times Cited: 5
Julia Carrasco-Zanini, Eleanor Wheeler, Burulça Uluvar, et al.
Nature Metabolism (2024)
Open Access | Times Cited: 5
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access
Vincent Chen, Graham F. Brady
Hepatology Communications (2025) Vol. 9, Iss. 1
Open Access
3D genomic features across >50 diverse cell types reveal insights into the genomic architecture of childhood obesity
Bao Khanh Trang, Matthew C. Pahl, James A. Pippin, et al.
eLife (2025) Vol. 13
Open Access
Bao Khanh Trang, Matthew C. Pahl, James A. Pippin, et al.
eLife (2025) Vol. 13
Open Access